On March 1, 2013; The FDA issued an order to Cease Manufacturing of HCT/P's to a New York fertility center.  On April 30, 2014 - more than a year later - the FDA has given authorization for the center to resume limited HCT/P Manufacturing Operations.

on the FDA's Orders & Public Notifications Page.

RTL can help your center with Donor Eligibility and FDA Compliance issues.  Please contact us for information.